Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II Clinical Trial of Celecoxib in Persons with Genotype Positiv-261005126
University of Texas MD Anderson Cancer Center
Search grants from University of Texas MD Anderson Cancer Center
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Development of an Alcohol, Cannabis, and Sexual Assault Risk Reduction Program for High Risk College Women
Experimental examinations of the mechanisms that generate the responses of midbra
Role and Mechanism of Microtubule Nucleation within the Mitotic Spindle
Kidney Disease, Stroke and Cognitive Impairment
Development of Reproductive-Endocrine-Genetic Strategies in Animal Species
Recently added grants:
Training in the Next Generation in Respiratory Science
Hemodynamics of thrombosis after transcatheter aortic valve-in-valve implantation
SIV Pathogenesis in African Green Monkeys and Pigtailed Macaques
Dietary factors, biomarkers, metabolic pathways related to non-alcoholic fatty liver disease
Simultaneous multiplexed in situ fluorescence imaging of neuronal proteins and messenger RNAs
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN005126-003
Application #
7191425
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2005
Total Cost
Indirect Cost
Institution
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2006
N01 CN
Phase II Clinical Trial of Celecoxib in Persons with Genotype Positiv-261005126
/ University of Texas MD Anderson Cancer Center
NIH 2005
N01 CN
Phase II Clinical Trial of Celecoxib in Persons with Genotype Positiv-261005126
/ University of Texas MD Anderson Cancer Center
NIH 2004
N01 CN
Phase II Clinical Trial of Celecoxib in Persons with Genotype Positiv-261005126
/ University of Texas MD Anderson Cancer Center
NIH 2000
N01 CN
Phase II Clinical Trial of Celecoxib in Persons with Ge
Lynch, Patrick M. / University of Texas MD Anderson Cancer Center
$3,251,125
Publications
Lynch, Patrick M; Ayers, Gregory D; Hawk, Ernie et al.
(2010)
The safety and efficacy of celecoxib in children with familial adenomatous polyposis.
Am J Gastroenterol 105:1437-43
Comments
Be the first to comment on this grant